Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease
Background: Plasma metabolites could be suitable as predictive biomarkers for cardiovascular pathologies or death, thereby improving the prediction of protein biomarkers. The release of acylcarnitines may be altered after coronary artery disease (CAD) in subjects with recurrent clinical outcomes, an...
Saved in:
Main Authors: | Jairo Lumpuy-Castillo, Francisco J. Rupérez, Brenda Lee Simas Porto, Carmen Cristóbal, Nieves Tarín, Ana Isabel Huelmos, Joaquín Alonso, Jesús Egido, Ignacio Mahíllo-Fernández, Lorenzo López-Bescós, José Tuñón, Óscar Lorenzo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/27 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study
by: Zhihao Fang, et al.
Published: (2025-01-01) -
Development and internal validation of a metabolism-related model for predicting 30-day mortality in neonatal sepsis
by: Xiangwen Tu, et al.
Published: (2025-01-01) -
Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease and vascular parkinsonism
by: A. A. Makarova, et al.
Published: (2025-01-01) -
A machine learning model accurately identifies glycogen storage disease Ia patients based on plasma acylcarnitine profiles
by: Joost Groen, et al.
Published: (2025-01-01) -
Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
by: O. Lorenzo, et al.
Published: (2013-01-01)